A5077517476- COVID-19 Clinical Research Studies
- Long-Term Effects of COVID-19
- Metabolism and Genetic Disorders
- Peroxisome Proliferator-Activated Receptors
- Autoimmune and Inflammatory Disorders Research
- SARS-CoV-2 and COVID-19 Research
- Sepsis Diagnosis and Treatment
- COVID-19 diagnosis using AI
- Diabetes and associated disorders
Sağlık Bilimleri Üniversitesi
2020-2021
Gaziosmanpaşa Taksim Eğitim ve Araştırma Hastanesi
2020
The aim of the study was to analyze usefulness CURB-65 and pneumonia severity index (PSI) in predicting 30-day mortality patients with COVID-19, identify other factors associated higher mortality.A retrospective performed a pandemic hospital Istanbul, Turkey, which included 681 laboratory-confirmed COVID-19. Data on characteristics, vital signs, laboratory parameters were recorded from electronic medical records. Receiver operating characteristic analysis used quantify discriminatory...
In this study, laboratorial parameters of hospitalized novel coronavirus (COVID-19) patients, who were complicated with severe pneumonia, compared the findings cytokine storm developing in macrophage activation syndrome (MAS)/secondary hemophagocytic lymphohistiocytosis (sHLH). Severe pneumonia occurred as a result some patients needed intensive care unit (ICU), and it is aimed to determine precursive situation. Also aim identify laboratory criteria that predict worsening disease ICU...
BackgroundThe clinical spectrum of COVID-19 has a great variation from asymptomatic infection to acute respiratory distress syndrome and eventually death. The mortality rates vary across the countries probably due heterogeneity in study characteristics patient cohorts as well treatment strategies. Therefore, we aimed summarize outcomes adult patients hospitalized with laboratory-confirmed pneumonia Istanbul, Turkey.MethodsA total 722 were analyzed this single-center retrospective between...
Abstract In Coronavirus disease 2019 (COVID-19), it is important to evaluate activity and investigate possible biomarkers. Therefore, in this study, we investigated the relationship between serum levels of immune activation marker neopterin patients with COVID-19. The study enrolled 45 (23 females, 51.1%) treated for were divided into two groups according their clinical presentation: those who recovered quickly (Group 1) worsened progressively 2). C-reactive protein high all on admission....